近端胃切除双通道重建与全胃切除在胃及胃食管结合部癌中的系统评价与荟萃分析:临床决策证据仍不充分
该系统评价与荟萃分析比较近端胃切除双通道重建与全胃切除在胃食管结合部(AEG II-III)及胃癌患者中的效果,纳入1项RCT和13项非RCT共1317例患者。近端胃切除双通道重建在术后/术前体重比、血红蛋白比及术后维生素B12水平上更优,但肿瘤学有效性无法评估(GRADE极低质量证据)。
要点
- 近端胃切除双通道重建在术后营养参数(体重比、血红蛋白比、维生素B12)上优于全胃切除,证据质量中等。
- 全胃切除组进展期比例更高,导致生存比较存在异质性偏倚,肿瘤学有效性无法评估(GRADE极低)。
- 围手术期参数两种术式相当,健康相关生活质量仅2项研究报告且无显著优势。
核心结论
- 近端胃切除双通道重建相比全胃切除在术后营养参数上具有优势(GRADE中等质量证据)。
- 近端胃切除双通道重建的肿瘤学有效性无法评估(GRADE极低质量证据)。
- 需要进一步精心设计的随机对照试验(尤其在西方患者队列中)以改善胃癌患者的治疗决策。
研究设计与样本
- 系统检索Medline、Web of Science和Cochrane Library截至2021年12月20日(PROSPERO注册号CRD42021291500)。
- 纳入1项随机对照试验和13项非随机对照研究,共1317例患者(全胃切除715例,近端胃切除双通道重建602例)。
- 使用修订版Cochrane偏倚风险工具和ROBINS-I工具评估偏倚风险,采用GRADE方法评级证据质量。
主要发现
- 两种术式围手术期参数相当。
- 健康相关生活质量数据仅2项研究报告,未发现近端胃切除双通道重建的显著优势。
临床怎么用
- 近端胃切除双通道重建在术后营养参数(体重、血红蛋白、维生素B12)上可能优于全胃切除,但需考虑证据质量中等。
- 由于肿瘤学有效性证据极低且存在异质性偏倚,临床决策需谨慎,不应仅凭生存观察结果选择术式。
- 围手术期参数两者相当,健康相关生活质量数据有限,需个体化评估。
局限性
- 仅纳入1项随机对照试验,多数为非随机对照研究,证据等级受限。
- 全胃切除组进展期比例显著更高,导致生存比较存在异质性偏倚。
- 健康相关生活质量数据仅来自2项研究,信息不足。
- 肿瘤学有效性无法评估(GRADE极低质量证据)。
- 需要西方患者队列的进一步随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare proximal gastrectomy with double-tract reconstruction and total gastrectomy in patients with gastroesophageal junction (AEG II-III) and gastric cancer. METHODS: We conducted systematic searches in Medline, Web of Science, and Cochrane Library until December 20, 2021 (PROSPERO registration number: CRD42021291500). Risk of bias was assessed using the revised Cochrane risk of bias tool and the ROBINS-I tool, as applicable. Evidence was rated by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. RESULTS: One randomized controlled trial (RCT) and 13 non-RCTs with 1,317 patients (715 patients with total gastrectomy and 602 patients with proximal gastrectomy with double-tract reconstruction) were included. Patients treated by total gastrectomy had a significantly higher proportion of advanced cancer stages International Union Against Cancer IB-III (odds ratio: 0.68, 95% confidence interval: 0.51-0.91, P = .01). This heterogeneity biases the observed improved overall survival of patients after proximal gastrectomy with double-tract reconstruction (odds ratio: 0.67, 95% confidence interval: 0.44-1.01, P = .05). Both procedures were comparably efficient regarding perioperative parameters. Postoperative/preoperative bodyweight ratio (mean difference: 3.56, 95% confidence interval: 1.32-5.79, P = .002), postoperative/preoperative serum-hemoglobin ratio (mean difference 3.73, 95% confidence interval: 1.59-5.88, P < .001), and postoperative serum vitamin B12 levels (mean difference 42.46, 95% confidence interval: 6.37-78.55, P = .02) were superior after proximal gastrectomy with double-tract reconstruction, while postoperative/preoperative serum-albumin ratio (mean difference 1.24, 95% confidence interval: -4.76 to 7.24, P = .69) and postoperative/preoperative serum total protein ratio (mean difference 1.12, 95% confidence interval: -2.77 to 5.00, P = .57) were not different. Health-related quality of life data were reported in only 2 studies, which found no significant advantages for proximal gastrectomy with double-tract reconstruction. CONCLUSION: Proximal gastrectomy with double-tract reconstruction offers advantages in postoperative nutritional parameters compared to total gastrectomy (GRADE: moderate quality of evidence). Oncological effectiveness of proximal gastrectomy with double-tract reconstruction cannot be assessed (GRADE: very low quality of evidence). Further thoroughly planned randomized controlled trials in Western patient cohorts are necessary to improve treatment for gastric cancer patients.
引用
- Hipp J, Hillebrecht HC, Kalkum E, et al. Systematic review and meta-analysis comparing proximal gastrectomy with double-tract-reconstruction and total gastrectomy in gastric and gastroesophageal junction cancer patients: Still no sufficient evidence for clinical decision-making. Surgery. 2022. PMID: 36543733. doi:10.1016/j.surg.2022.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。